Genpact LTD — Director's Dealing 2023

Feb 3, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Genpact LTD (G)
CIK: 0001398659
Period of Report: 2023-02-01

Reporting Person: Tyagarajan N. V. (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-01	Common Shares	M	50000	$19.35	Acquired	672518	Direct
2023-02-01	Common Shares	S	50000	$47.4188	Disposed	622518	Direct
2023-02-02	Common Shares	M	50000	$19.35	Acquired	672518	Direct
2023-02-02	Common Shares	S	50000	$47.6025	Disposed	622518	Direct
2023-02-03	Common Shares	M	50000	$19.35	Acquired	672518	Direct
2023-02-03	Common Shares	S	50000	$47.1048	Disposed	622518	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-02-01	Employee Stock Option (Right to Buy)	$19.35	M	50000	Disposed	2023-05-30	Common Shares (50000)	Direct
2023-02-02	Employee Stock Option (Right to Buy)	$19.35	M	50000	Disposed	2023-05-30	Common Shares (50000)	Direct
2023-02-03	Employee Stock Option (Right to Buy)	$19.35	M	50000	Disposed	2023-05-30	Common Shares (50000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	10000	Indirect

Footnotes

F1: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $47.02 to $47.80. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F2: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $47.21 to $47.92. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F3: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $46.83 to $47.47. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F4: These shares are held in trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is one of the trustees of the trust. The reporting person disclaims beneficial ownership of the reported securities held by the trust except to the extent of his pecuniary interest therein.

F5: The option vested 50% on January 10, 2016 and the remainder on January 10, 2018.